These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36288294)

  • 1. Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis.
    Narayana JK; Aliberti S; Mac Aogáin M; Jaggi TK; Ali NABM; Ivan FX; Cheng HS; Yip YS; Vos MIG; Low ZS; Lee JXT; Amati F; Gramegna A; Wong SH; Sung JJY; Tan NS; Tsaneva-Atanasova K; Blasi F; Chotirmall SH
    Am J Respir Crit Care Med; 2023 Apr; 207(7):908-920. PubMed ID: 36288294
    [No Abstract]   [Full Text] [Related]  

  • 2. Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis.
    Mac Aogáin M; Ivan FX; Jaggi TK; Richardson H; Shoemark A; Narayana JK; Dicker AJ; Koh MS; Lee KCH; Thun How O; Poh ME; Chin KK; Hou ALY; Ser Hon P; Low TB; Abisheganaden JA; Dimakou K; Digalaki A; Kosti C; Gkousiou A; Hansbro PM; Blasi F; Aliberti S; Chalmers JD; Chotirmall SH
    Am J Respir Crit Care Med; 2024 Jul; 210(1):47-62. PubMed ID: 38271608
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.
    Cox MJ; Turek EM; Hennessy C; Mirza GK; James PL; Coleman M; Jones A; Wilson R; Bilton D; Cookson WO; Moffatt MF; Loebinger MR
    PLoS One; 2017; 12(2):e0170622. PubMed ID: 28170403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gut mycobiome of the Human Microbiome Project healthy cohort.
    Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
    Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sputum neutrophil elastase associates with microbiota and
    Oriano M; Gramegna A; Terranova L; Sotgiu G; Sulaiman I; Ruggiero L; Saderi L; Wu B; Chalmers JD; Segal LN; Marchisio P; Blasi F; Aliberti S
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32499333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study.
    Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD
    Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis.
    Byun MK; Chang J; Kim HJ; Jeong SH
    PLoS One; 2017; 12(8):e0183553. PubMed ID: 28829833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung and Gut Microbiota Changes Associated with
    Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative microbiomics in bronchiectasis exacerbations.
    Mac Aogáin M; Narayana JK; Tiew PY; Ali NABM; Yong VFL; Jaggi TK; Lim AYH; Keir HR; Dicker AJ; Thng KX; Tsang A; Ivan FX; Poh ME; Oriano M; Aliberti S; Blasi F; Low TB; Ong TH; Oliver B; Giam YH; Tee A; Koh MS; Abisheganaden JA; Tsaneva-Atanasova K; Chalmers JD; Chotirmall SH
    Nat Med; 2021 Apr; 27(4):688-699. PubMed ID: 33820995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.
    Wang WW; Mao B; Liu Y; Gu SY; Lu HW; Bai JW; Liang S; Yang JW; Li JX; Su X; Hu HY; Wang C; Xu JF
    Respir Res; 2022 Nov; 23(1):317. PubMed ID: 36403022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung microbiome: new insights into bronchiectasis' outcome.
    Azoicai A; Lupu A; Alexoae MM; Starcea IM; Mocanu A; Lupu VV; Mitrofan EC; Nedelcu AH; Tepordei RT; Munteanu D; Mitrofan C; Salaru DL; Ioniuc I
    Front Cell Infect Microbiol; 2024; 14():1405399. PubMed ID: 38895737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
    Tunney MM; Einarsson GG; Wei L; Drain M; Klem ER; Cardwell C; Ennis M; Boucher RC; Wolfgang MC; Elborn JS
    Am J Respir Crit Care Med; 2013 May; 187(10):1118-26. PubMed ID: 23348972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing.
    Xiao S; Zhang G; Jiang C; Liu X; Wang X; Li Y; Cheng M; Lv H; Xian F; Guo X; Tan Y
    Front Cell Infect Microbiol; 2021; 11():605825. PubMed ID: 33869074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap.
    Tiew PY; Jaggi TK; Chan LLY; Chotirmall SH
    Clin Respir J; 2021 Feb; 15(2):123-133. PubMed ID: 33063421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microbiome in bronchiectasis.
    Richardson H; Dicker AJ; Barclay H; Chalmers JD
    Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31484665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the gut microbiota of AIDS patients with pneumocystis pneumonia and correlations with the lung microbiota.
    Zhu M; Liu S; Zhao C; Shi J; Li C; Ling S; Cheng J; Dong W; Xu J
    Front Cell Infect Microbiol; 2022; 12():1033427. PubMed ID: 36339339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sputum metagenomics of people with bronchiectasis.
    Rosenboom I; Thavarasa A; Richardson H; Long MB; Wiehlmann L; Davenport CF; Shoemark A; Chalmers JD; Tümmler B
    ERJ Open Res; 2024 Mar; 10(2):. PubMed ID: 38444657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsupervised learning technique identifies bronchiectasis phenotypes with distinct clinical characteristics.
    Guan WJ; Jiang M; Gao YH; Li HM; Xu G; Zheng JP; Chen RC; Zhong NS
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):402-10. PubMed ID: 27046724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.